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BENEFITS OF THORACIC EPIDURAL ANALGESIA IN PATIENTS 
UNDERGOING AN OPEN POSTERIOR COMPONENT SEPARATION FOR 
ABDOMINAL HERNIORRHAPHY 
 
AUSTIN SELLERS 
ABSTRACT 
Introduction: The implementation of open posterior component separation (PCS) 
surgery has led to improved outcomes for complex hernias. While the PCS technique has 
been shown to decrease recurrence rates, and provide a feasible option to repair hernias in 
nontraditional locations, there is still significant postoperative pain associated with the 
laparotomy and extensive abdominal wall manipulation. Systemic opioids and thoracic 
epidural analgesia (TEA) are both commonly utilized, either together or independently, 
as postoperative analgesic regimens. The benefits of TEA have been studied following a 
variety of surgeries, however to date no study has been performed to investigate its 
efficacy in this particular surgery. The aim of this study is to evaluate the benefits of TEA 
following open PCS. We hypothesized that the incorporation of TEA in a patients 
postoperative analgesic regimen would show an advantage in time to bowel recovery. 
Methods: An electronic medical record query was done to identify patients who had 
undergone an open PCS. Once this list was compiled, a retrospective chart review was 
performed and patients receiving TEA (either alone or combined with systemic opioids) 
were compared to patients receiving only systemic opioids. The primary endpoint 
compared time to resumption of a full diet, given by the patients postoperative day 
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(POD). Secondarily, time to resumption of a liquid diet, postoperative length of stay 
(LOS), intensive care unit (ICU) admission rate, ICU LOS, and rates of several 
postoperative complications were all recorded and compared. A post-hoc analysis was 
also performed using the same endpoints. This analysis compared cohorts of patients 
receiving TEA and avoiding all systemic opioids, to patients who received systemic 
opioids (whether alone or combined with TEA). 
Results: Based on inclusion parameters, 101 patients met criteria for analysis. In the 
initial analysis, 62 patients received TEA with or without systemic opioids, and 39 
patients received only systemic opioids. In comparing these groups, there was no 
statistically significant difference in time to full diet (TEA 2.6 ± 1.7 vs Systemic opioids 
3.1 ± 2.1 [mean POD ± SD]; P=0.21). In addition, no differences were found in the 
secondary outcomes of time to liquid diet, ICU admission, ICU LOS, or postoperative 
complications. In the post-hoc analysis, the 37 patients that received only TEA, were 
compared against 64 patients that received systemic opioids (either with or without 
TEA). In this comparison, the group receiving only TEA was found to have a statically 
shorter time to bowel recovery compared to patients receiving systemic opioids (TEA 
alone 2.2 ± 1.0 vs Systemic opioids 3.2 ± 2.2, P=0.0033). This subgroup (TEA only) also 
showed statically shorter time to liquid diet and a decreased postoperative LOS.  
Conclusion:  For patients undergoing an open PCS, the inclusion of TEA in the 
postoperative analgesic regimen did not shorten return of bowel function. However, when 
TEA was utilized and systemic opioids were avoided, time to bowel recovery and 
hospital LOS were both significantly shortened.  
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INTRODUCTION 
 
 Each year, an estimated 200,000 inguinal hernia repairs are performed in the 
United States and one of the most common procedures performed in general surgery is 
the open approach to herniorrhaphy.7 However, surgical repair can be challenging with 
certain types of hernias (non-midline, suprapubic, parastomal, or subxiphoid). 
Additionally, a high rate of recurrence serves as a driving force in the need for an 
improved approach to hernia repair. Anterior component separation (a proposed 
approach) has a recurrence rate of 16 to 27 percent. 15,21,31 In an attempt to combat these 
problems, several surgical techniques have been proposed as the new standard for 
challenging hernia cases, in order to cut down on recurrence and improve surgical 
outcomes.16 
 The technique which has proven most useful in lowering recurrence rates while 
also allowing for complex cases to be resolved, is an open approach to hernia repair with 
a posterior component separation (PCS).20 This technique begins with a midline 
laparotomy incision followed by removal of any posterior wall adhesions, and extensive 
dissection of the abdominal wall muscle layers. After each of the layers have been 
separated from one another, a posterior layer (composed of transversalis fascia, posterior 
rectus sheath, and peritoneum) is closed as one unit along the midline. After closure, a 
large sheet of mesh is then placed between this layer and what will become the anterior 
layer (transversus abdominus and rectus abdominus).16 Electing for this approach has 
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shown to result in a lower rate of recurrence as well as an improvement in abdominal 
wall function, which correlates with a higher quality of life.9,16 
 Due to the fact this is an invasive procedure with considerable tissue 
restructuring, a proactive and aggressive approach to postoperative pain control is 
necessary. One option to address postoperative pain in this patient population is thoracic 
epidural analgesia (TEA), which is commonly utilized as a component of the analgesic 
regimen following major abdominal and thoracic surgery. Another potential method of 
pain relief is intravenous (IV) opioids, the IV route is preferred until patient bowel 
recovery has occurred. However, in various meta-analyses and systemic reviews, TEA 
has been shown to provide superior analgesia following other types of abdominal 
surgeries, and also carries with it a reduced rate of pulmonary complications, decreased 
postoperative catabolism, and a decreased duration of postoperative ileus when compared 
to a regimen consisting of systemic opioids.4,23,32 
 Postoperative ileus (or paralytic ileus) is described as a functional inhibition of 
propulsive bowel activity.22 This condition is often exacerbated following surgeries which 
require bowel manipulation or peritoneal irritation.1 This unintended result of most, if not 
all, abdominal surgeries creates the need for patients to have longer hospital stays, 
increasing the total cost of their hospital encounter and can bring about increased levels 
of discomfort throughout their stay, in some cases requiring additional analgesia.  
 In rodent studies, three potential mechanisms for ileus have been proposed 
(neurogenic, inflammatory, and pharmacological).1 Studies done on the neuronal 
component to postoperative ileus (POI), show that neuronal mechanisms contribute a 
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significant role in the hours after surgery. However, they seem to have an effect over the 
course of several hours after surgery, which doesn’t account for the total length of ileus 
(48-72 hrs).14 A second contributing factor is the immunologic response to surgery. 
Several leukocytes have been shown to invade tissue in response to acute injury. As 
macrophages become active, they secrete cytokines, nitric oxide (NO), prostaglandins, 
and reactive oxygen species in order to mediate inflammation and respond to the 
insulting agent.1 The release of these mediators has been shown to affect the function of 
enteric nerves and thus is seen as a contributing factor to POI.8 
  
Clinically, opioids are frequently prescribed as a part of the analgesic regimen in 
abdominal surgery. However, the mechanism of action only serves to prolong POI. 
Studies have shown that opioids interfere with gastrointestinal motility and in vivo studies 
further demonstrate that δ and μ- opioid agonists abolish peristaltic activity in monkey, 
dog and man.2,3 The receptor mediated response is still debated and further study is 
needed to characterize the individual roles of specific receptors.  
 
Compared to the delay in bowel motility that results from opioid usage, there is a 
plethora of supportive data which shows TEA can provide enhanced bowel recovery. A 
notable benefit of TEA is sympathetic nervous system blockade, leaving parasympathetic 
activity unhindered and resulting in GI motility.30 The injection of local anesthetic into 
the epidural space creates a stabilization of membrane potential and thus actively blocks 
neuronal output. The duration of blockade is dependent on the medications used.33 
Additionally, the use of TEA often proves to be effective in providing postoperative 
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analgesia, lowering or eliminating the need for subsequent systemic opioids. This serves 
an important role, as systemic opioids have been shown to increase bowel dysfunction 
and contribute to the pharmacological prolonging of POI.12 
 The ability of TEA to hasten bowel recovery has been demonstrated following 
abdominal vascular surgery, gastrointestinal surgery, and even in some non-abdominal 
surgeries, such as scoliosis correction.5,11,13 However, in other intra-abdominal surgery, 
such as abdominal hysterectomy, similar benefits have not been demonstrated and 
therefore TEA is not a routinely recommended course of analgesia.17,19 Based on these 
conflicting findings, the necessity to investigate the efficacy of TEA for an open 
component separation is warranted. Secondary to the invasive nature of the surgery, the 
significant reconstruction that is required, and the postoperative ileus that often results 
from the procedure, the study was designed to provide data to help guide clinical decision 
making related to analgesia following this particular surgery.  
To the authors’ knowledge, no prior study had investigated the benefits of 
continuous TEA for patients undergoing an open PCS for abdominal herniorrhaphy. This 
study was designed to retrospectively compare the use of TEA, either alone or in concert 
with systemic opioids, to patients receiving only systemic opioids for postoperative 
analgesia. The proposed hypothesis was that patients receiving TEA would have faster 
return of bowel function. Under the same hypothesis, a secondary analysis of the data 
was performed to compare the use of TEA alone against patients receiving any systemic 
opioid, whether administered alone or in combination with TEA. In both the primary and 
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secondary analyses, the data used to signify return of bowel function, was the 
postoperative time, defined in days, until a full diet was assumed by each patient.  
 6 
METHODS  
 
 After gaining approval by an Institutional Review Board, the retrospective chart 
study was undertaken. Due to the retrospective nature of the study, written informed 
consent was waived. The primary outcome was time to bowel recovery, which was 
defined as the postoperative day (POD) on which the patient was started on a full diet. 
Upon review, secondary outcomes included time to liquid diet, total hospital length of 
stay (LOS), incidence of intensive care unit (ICU) admission, ICU LOS, and rates of 
postoperative pneumonia, deep vein thrombosis (DVT), pulmonary embolism (PE), or 
postoperative mechanical ventilation/reintubation. 
 All patients had surgery on an inpatient basis at Wake Forest Baptist Medical 
Center (Winston Salem, North Carolina), a tertiary care university hospital. The 
institutional electronic medical record was initially queried to identify patients with the 
term “component separation” listed in their surgical posting during the time period 
between March 1st, 2013 and September 1st, 2016.  For these patients, the full surgical 
posting and operative note was then reviewed to further identify those patients that 
underwent an open posterior component separation. 
 Criteria which excluded patients from analysis included having the procedure 
done laparoscopically or at another affiliated hospital within the medical system. 
Additionally, if during review of the surgical note, it was discovered that the patient 
received a planned or unplanned surgery on the bowel, such as a colostomy/ileostomy 
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reversal or creation, bowel resection, or enterotomy repair, the patient was excluded from 
analysis. 
 For each eligible patient, several data points were analyzed from their charts. 
Patient demographic data such as age, gender, body mass index (BMI) was recorded; 
along with data related to each individual surgery, such as surgical side, surgeon 
performing the operation, and total surgical duration. In addition to this information, each 
patient’s medical history and documented problem list was reviewed and the resulting 
information was utilized to calculate a Charlson Comorbidity Index (CCI).27 This indexed 
score sums comorbidities, individually weighted, to provide a mortality predictor. For the 
purpose of this study, a patient’s CCI value was used comparatively to analyze the 
relative health of the study cohorts.  
 The anesthetic and postoperative records for each patient were then reviewed to 
determine if TEA and/or systemic opioids (parenteral or enteral) were administered for 
postoperative pain control. If the patient received a TEA as a component of their pain 
control plan, several additional data points were recorded, including the duration of use, 
concentration of local anesthetic, and dose of epidural opioids. If the TEA was attempted 
and could not be successfully placed, or if TEA was determined to have failed (was 
removed on postoperative day 0 or 1) then the patient was placed in the systemic opioid 
cohort. Potential reasons for TEA failure were inadequate analgesia or intolerance, such 
as hypotension. When systemic opioids were the only means of analgesia, the 
administration route and dosage were recorded. If systemic opioids were added to TEA 
due to inadequate analgesia, intolerance, or as a part of the initial analgesia plan (for 
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example as a continuation of a patient’s normal regimen for chronic pain) then the patient 
was included in the TEA cohort.  
 The order history was reviewed to determine which POD the patient was 
advanced from nothing per os (NPO) to a liquid diet, and subsequently to a solid food 
diet. This information was recorded, using the day of surgery as POD 0. If the patient’s 
diet was altered due to any complications (ileus, vomiting, nausea) and then re-advanced 
at a later date, the POD used was the last POD on which the patient was successfully 
advanced to that particular stage of diet. In addition, the POD on which the patient was 
discharged was recorded to determine the total length of stay (LOS). The chart was 
reviewed to determine if any post-operative complications occurred, specifically the need 
for reintubation, diagnoses of pneumonia, or the presence of DVT/PE. If a patient was 
admitted to the ICU for any reason, the ICU LOS was also recorded.  
 The primary and secondary outcomes were defined prior to collection of data, 
with the initial hypothesis being that the use of TEA (alone or in concert with systemic 
opioids) would provide quicker bowel recovery time when compared to systemic opioids 
alone.  
 A post hoc analysis was also performed to further investigate the effects of 
postoperative opioid administration on bowel recovery. The analysis compared patients 
which received TEA and avoided postoperative opioids altogether, with patients 
receiving any opioids as a part of their postoperative care regimen, whether alone or in 
combination with TEA. In this analysis, the same primary and secondary outcomes were 
utilized. Data were analyzed using SAS™, version 9.4 (SAS Institute Inc., Cary, NC). To 
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test for differences between groups, patient characteristics were analyzed using 
independent t-tests for continuous variables and Fisher exact tests for categorical 
variables with a conventional α level of 0.05. 
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RESULTS 
 
 
 When querying the electronic records system, a total of 132 patients were 
identified as having “component separation” in their surgical posting during the specified 
time of investigation. Of these, 3 had surgery at an off-site affiliated hospital, 4 had their 
procedure done laparoscopically, and 21 had concurrent bowel surgery. In addition, after 
reviewing the operative note, it was found that 3 patients didn’t have a PCS performed. 
As Detailed in Figure 1, there were 101 patients included in the final analysis. Of these 
37 patients received TEA alone for their analgesic regimen, 25 received a combination of 
TEA and systemic opioids, and 39 had only systemic opioids for analgesia. 
  Figure 1: Patient Cohort Composition 
 
 
Total Patients 
(101)
Patients 
Receiving TEA 
(37)
Patients 
Receiving TEA + 
Systemic Opioids 
(25)
Patients 
Receiving 
Systemic Opioids 
(39)
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Table 1: Demographics for primary analysis (thoracic epidural, with and without 
systemic opioids, versus systemic opioids alone) 
 
 
As detailed in Table 1, the original comparison between patients with TEA and 
patients with systemic opioids showed no difference in age, BMI, gender, or comorbidity 
burden. There also was no difference in surgical duration. Table 2 outlines the outcomes. 
In terms of the primary outcome (time to solid food diet), no significant difference was 
found between the cohorts (Thoracic epidural 2.6 +/- 1.7 vs. Systemic opioids 3.1 +/- 2.1 
[mean POD +/- standard deviation]; P=0.21). Also, there was no significant difference 
found for time to liquid diet (1.1 +/- 1.5 vs. 1.4 +/- 1.9, P=0.45), total LOS (4.9 +/- 1.9 vs. 
5.8 +/- 4.0, P=0.21), or ICU LOS (0.3 +/- 1.0 vs. 0.6 +/- 1.4, P=0.29). Additionally, there 
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Table 1: Demographics for primary analysis (thoracic epidural, with and without 
systemic opioids, versus systemic opioids alone) 
 Thoracic Epidural ± 
Systemic Opioids (n=62) 
Systemic Opioids 
Alone (n=39) 
P-
value 
 Mean (SD)                        Median  
BMI  33.2 (7.3), 32.2 31.0 (7.4), 30.3 0.14 
Age (years) 57.7 (12.0), 60.0 54.4 (13.7), 56.0 0.20 
CCI 1.0 (1.7), 0.0 0.7 (1.2), 0.0 0.29 
Surgical duration (min) 256.4 (93.7), 227.5 228.2 (71.0), 215.0 0.11 
   n (%)  
Gender 
Male 
Female 
 
36 (58) 
26 (42) 
 
27 (69) 
12 (31) 
0.30 
 
As detailed in Table 1, the original comparison between patients with TEA and 
patients with systemic opioids showed no difference in age, BMI, gender, or comorbidity 
burden. There also was no difference in surgical duration. Table 2 outlines the outcomes. 
In terms of the primary outcome (time to solid food diet), no significant difference was 
found between the cohorts (Thoracic epidural 2.6 +/- 1.7 vs Systemic opioids 3.1 +/- 2.1
[mean POD +/- standard deviation]; P=0.21).  Also, there was no significant difference 
found for time to liquid diet (1.1 +/- 1.5 vs 1.4 +/- 1.9, P=0.45), total LOS (4.9 +/- 1.9 vs 
5.8 +/- 4.0, P=0.21), or ICU LOS (0.3 +/- 1.0 vs 0.6 +/- 1.4, P=0.29). Additionally, there 
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were no differences in rate of ICE admission, or incidences of postoperative 
ventilation/reintubation, DVT/PE, or pneumonia, shown between the two groups. 
 
Table 2: Outcomes for primary analysis (thoracic epidural, with and without 
systemic opioids, versus systemic opioids alone) 
 
 
The post hoc analysis regrouped patients into cohorts based on the administration 
of systemic opioids, rather than receiving a TEA. This then reorganized patients into two 
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were no diff r  in rate of ICE admission, or incidences of postoperative 
ventilation/reintubation, DVT/PE, or pneumonia, shown between the two groups.  
 
Table 2: t s for primary analysis (thoracic epidural, with and without 
systemic opioids, versus systemic opioids alone) 
 Thoracic Epidural ± 
Systemic Opioids 
(n=62) 
Systemic Opioids 
Alone (n=39) 
P-value  
            Mean (SD)                       Median  
Time to solid food (days) 2.6 (1.7), 2.0 3.1 (2.1), 3.0 0.21 
Time to liquid food (days) 1.1 (1.5), 1.0 1.4 (1.9), 0.0 0.45 
Total length of stay (days) 4.9 (1.9), 4.0 5.8 (4.0), 4.0 0.21 
ICU length of stay (days) 0.3 (1.0), 0.0 0.6 (1.4), 0.0 0.29 
     n (%)  
ICU admission 8 (13) 8 (21) 0.40 
Pneumonia 0 (0) 1 (3) 0.39 
Postoperative intubation 2 (3) 3 (8) 0.37 
DVT or PE 0 (0) 1 (3) 0.39 
ICU=intensive care unit; DVT=deep venous thrombosis; PE=pulmonary embolism 
 
 The post hoc analysis regrouped patients into cohorts based on the administration 
of systemic opioids, rather than receiving a TEA. This then reorganized patients into two 
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groups, those receiving only TEA as a means of postoperative pain control, and those 
who received systemic opioids alone as well as in concert with TEA. The breakdown of 
patients making up each comparison group is illustrated in Figure 2.  
 Figure 2: Breakdown of Analysis-Primary and Post-Hoc 
 
After regrouping, 37 patients remained in the TEA only group, and 64 in the systemic 
opioid group (with or without receiving TEA). Similar to the first comparison, the 
cohorts did not differ in BMI, gender, comorbidity burden, or duration of surgery (Table 
3), however the group receiving only TEA was statistically older compared to the 
systemic opioid group (61.5 +/- 9.9 vs 53.5 +/- 13.3, P=0.002). 
 
 
Total Patients 
(101)
Analysis 1
Patients Receiving 
TEA with or 
without Systemic 
Opioids (62)
Patients Receiving 
Systemic Opioids 
(29)
Analysis 2 (Post-
Hoc)
Patients Receiving 
TEA (37)
Patients Receiving 
Systemic Opioids 
with or without 
TEA (64)
 14 
Table 3: Demographics for post-hoc analysis (thoracic epidural alone versus 
systemic opioids, with or without thoracic epidural) 
 
BMI=body mass index; n=number; SD=standard deviation; CCI=Charlson comorbidity index 
*Statistically significant difference between groups (P <0.05) 
 
All patients that received systemic opioids had them administered via a patient 
controlled analgesia (PCA) device that was maintained until the TEA was discontinued, 
or until they resumed a full diet. All thoracic epidurals contained bupivacaine as the local 
anesthetic at a concentration of either 0.125% or 0.25% (Table 4). The addition of 
epidural opioids to the local anesthetic varied, as did the type and concentration of the 
epidural opioid (Table 4). 
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Table 3: De ographics for post-hoc analysis (thoracic epidural alone versus 
s i  opioids, with or without thoracic epidural) 
 Thoracic 
Epidural Alone 
(n=37) 
Systemic Opioids ± 
Thoracic Epidural 
(n=64) 
P-value 
       Mean (SD)                        Median  
BMI (kg/m2) 33.0 (7.0), 32.7 31.9 (7.6), 30.9 0.47 
Age (years) 61.5 (9.9), 62.0 53.5 (13.3), 55.0 0.002* 
CCI 0.9 (1.6), 0.0 0.8 (1.5), 0.0 0.75 
Surgical duration (min) 239.8 (76.2), 224.0 248.8 (92.2), 221.5 0.62 
 n (%)  
Gender 
Male 
Female 
 
21 (57) 
16 (43) 
 
42 (66) 
22 (34) 
0.40 
BMI=body mass index; n=number; SD=standard deviation; CCI=Charlson comorbidity index  
*Statistically significant difference between groups (P <0.05) 
 
All patients that received systemic opioids had them administered via a patient 
controlled analgesia (PCA) device that was maintained until the TEA was discontinued, 
or until they resumed a full diet. All thoracic epidurals contained bupivacaine as the local 
anesthetic at a concentration of either 0.125% or 0.25% (Table 4). The addition of 
epidural opioids to the local anesthetic varied, as did the type and concentration of the 
epidural opioid (Table 4). 
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Table 4: Epidural Local Anesthetic Concentrations and Opioids 
 
 
 
The outcomes from the post hoc grouping are shown in Table 4. The TEA group 
not only had significantly shorter time to solid food (2.2 +/- 1.0 vs. 3.2 +/- 2.2, 
P=0.0033), but also had significantly shorter time to liquid diet (0.7 +/- 1.0 vs. 1.5 +/- 
1.9, P=0.0084), and a shorter hospital LOS (4.5 +/- 1.7 vs. 5.6 +/- 3.3, P=0.032), when 
compared to the systemic opioid (only?) group. However, no differences were found in 
ICU admission rate, ICU LOS, or incidences of mechanical ventilation/reintubation, 
DVT/PE, or pneumonia. 
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Table i ral Local Anesthetic Concentra ions a d Opioids  
 Thoracic 
Epidural Alone 
(n=37) 
Thoracic Epidural and 
Systemic Opioids 
(n=25) 
0.25% Bupivacaine 0 8 
0.25% Bupivacaine + 2 mcg/ml 
hydromorphone 
29 12 
0.25% Bupivacaine + 5 mcg/ml fentanyl 1 0 
0.125% Bupivacaine 0 1 
0.125% Bupivacaine + 5 mcg/ml 
hydromorphone 
4 2 
0.125% Bupivacaine + 10 mcg/ml 
hydromorphone 
5 2 
 
 
The outcomes from the post hoc grouping are shown in Table 4. The TEA group 
not only had significantly shorter time to solid food (2.2 +/- 1.0 vs 3.2 +/- 2.2, P=0.0033), 
but also had significantly shorter time to liquid diet (0.7 +/- 1.0 vs 1.5 +/- 1.9, P=0.0084), 
and a shorter hospital LOS (4.5 +/- 1.7 vs 5.6 +/- 3.3, P=0.032), when compared to the 
systemic opioid (only?) group. However, no differences were found in ICU admission 
rate, ICU LOS, or incidences of mechanical ventilation/reintubation, DVT/PE, or 
pneumonia.  
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Table 5: Outcomes for post-hoc analysis (thoracic epidural alone versus systemic 
opioids, with or without thoracic epidural) 
 
ICU=intensive care unit; DVT=deep venous thrombosis; PE=pulmonary embolus 
*Statistically significant difference between groups (P <0.05). 
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Table 5: Outcomes for post-hoc analysis (thoracic epidural alone versus systemic 
i i s, it  or without thoracic epidural) 
 Thoracic Epidural 
Alone (n=37) 
Systemic Opioids ± 
Thoracic Epidural 
(n=64) 
P-value 
         Mean (SD)                        Median  
Time to solid food (days) 2.2 (1.0), 2.0 3.2 (2.2), 2.0 0.0033* 
Time to liquid food (days) 0.7 (1.0), 1.0 1.5 (1.9), 1.0 0.0084* 
Total length of stay (days) 4.5 (1.7), 4.0 5.6 (3.3), 5.0 0.032* 
ICU length of stay (days) 0.3 (1.0), 0.0 0.5 (1.3), 0.0 0.44 
 n (%)  
ICU admission 5 (14) 11 (17) 0.78 
Pneumonia 0 (0) 1 (2) >0.99 
Postoperative intubation 2 (5) 3 (5) >0.99 
DVT or PE 0 (0) 1 (2) >0.99 
I intensive care unit; DVT=deep venous thr mbosis; PE=pulmonary embolus                                
*Statistically significant difference between groups (P <0.05). 
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DISCUSSION 
 
 TEA have been used as an effective strategy for controlling postoperative pain in 
several types of abdominal surgeries, and a recent meta-analysis has shown that the use 
of TEA may shorten LOS and improve GI motility following surgery when compared to 
systemic opioids.13 However, the data compiled in such a large study encompassing 
several types of surgery and several study parameters, make extrapolation to a specific 
patient population difficult. This is the case for open abdominal wall repair. Currently, 
there is a lack of literature comparing the analgesic and POI-related benefit to using TEA 
in open PCS. While one could assume that an extrapolation of the findings from previous 
studies related to the advantage of using TEA for this type of procedure, it has not proven 
to be an advantageous option of analgesia in all types of abdominal surgeries.17 This is 
demonstrated by the fact that several conflicting studies have been published concerning 
the effect of TEA on intestinal motility following abdominal hysterectomies.10,17 
Therefore, the goal of this retrospective study is to provide an evaluation of the potential 
benefits that TEA may provide when utilized as an analgesic regimen following 
herniorrhaphy by open PCS in the absence of simultaneous bowel surgery. 
 The initial hypothesis was that based on its action as a sympathetic nervous 
system blocker, any inclusion of TEA in a patient’s postoperative analgesic plan would 
provide a benefit in time to bowel recovery, regardless of the administration of additional 
systemic opioids. This data point was to be determined based on time to resumption of a 
full solid diet. However, the results showed that there was no difference in time to full 
diet, or in total length of stay following surgery. 
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 Following data collection, a secondary analysis was performed to determine 
whether the use or avoidance of systemic opioids, rather than the use of TEA, affected 
bowel recovery time and hospital LOS. Therefore, a second comparison between the 
using the same data set was performed, however the groups were redistributed so that 
patients having TEA only could be compared to all patients that received systemic 
opioids, whether alone or in concert with TEA.  
 This secondary analysis revealed that patients receiving any systemic opioids as a 
part of their postoperative analgesic regimen had a significantly slower postoperative 
recovery, requiring on average a one-day increase in the time until advancement to a diet 
of solid food. In addition to our primary outcome (time to solid food diet), patients 
receiving any systemic opioids took approximately one-day longer to be advanced to a 
liquid diet, and a greater than one-day longer hospital LOS on average. These findings 
were interesting, because unlike studies done under similar conditions with different 
procedures, the patients attained significant results in multiple relevant outcomes, time to 
liquid and full diet along with total length of stay.  
 The results from the original comparison did not support the original hypothesis. 
However, the negative findings coupled with the outcomes of the secondary analysis 
provide compelling support for the clinical use of TEA in this patient population. Rather 
than making an argument for including TEA in a patient’s analgesic regimen, the 
argument now becomes how to incorporate TEA without having to subsequently provide 
systemic opioids for pain control. This combination appears to allow for patients to 
assume a normal diet and ultimately leave the hospital sooner.  
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 Both comparisons found no difference in morbidity between groups, as defined by 
rate of postoperative ventilation/reintubation, pneumonia, or DVT/PA. However, 
previous investigations have shown a reduced incidence in all of these complications 
when TEA is incorporated into the analgesic plan.24,26,29 Given the low frequency of these 
events, it is very possible that this study may not have been large enough to detect a 
difference in their occurrence. 
 In addition to patient time in the hospital, there is a need to relieve the burden that 
postoperative ileus puts on the health economy. The total estimated annual cost of 
postoperative ileus is 1.46 billion dollars6. Thus, it is important to identify postoperative 
analgesic regimens that reduce the length of postoperative ileus and lessen the financial 
burden on health care. A study involving patients undergoing open colectomies found 
that the total cost of care was significantly higher for patients who developed POI 
($16,612 vs $8,316; P< 0.05).  In addition to the cost, length of stay, amount of opioid 
received, rate of 30 day all-cause readmission to the hospital, and readmission in 
laparoscopic surgery have all been shown to be increased in patients with ileus.12 
 While all of this makes a compelling argument for using TEA in open PCS, there 
are some limitations in the study which warrant discussion. First, the fact that the study 
was done retrospectively introduces the potential for selection and/or classification 
biases. There is certainly the potential that those patients who consented to having TEA 
were different in some way than patients who declined TEA and received only systemic 
opioids. Also, given the small number of surgeons performing these cases, there could be 
a bias towards a preferred analgesic based on surgeon preference. TEA is also an 
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additional procedure which takes time and resources, so scheduling conflicts or clinical 
pressure could have limited the availability of anesthesiologists capable of performing 
neuraxial blockades, which could rule out the option of TEA based on scheduling alone. 
Additionally, the specific criteria by which a patient should to be advanced to a particular 
diet (liquid and subsequently solid) was not defined. Therefore, the decision to advance a 
patient to a particular diet was based on the clinical decision of that particular patients 
care team. While there was certainly overlap of care teams, not every patient had the 
same team to make that decision and therefore different criteria must have been met on a 
case by case basis for advancement of diet.  
 Based on review of the data, 25 of the 62 patients treated with TEA had IV 
opioids by PCA added prior to POD2. The combination of TEA and IV opioids was 
planned only in 9 of those cases, likely due to chronic opioid use. The other 16 cases 
were given IV opioids due to potential adverse outcomes such as hypotension or 
inadequate analgesia. An additional 8 patients were deemed to have an epidural that 
failed. The criterion for a “failed” epidural was removal on postoperative day 0 or 1.  
This brought the overall failure rate (necessity for unintended IV opioid administration) 
to 24/70 or 34%. While this rate may seem high, a 32% failure rate was previously 
reported from a similar academic training facility.28 The acute pain service at Wake 
Forest Baptist Medical Center places high priority on achieving early pain relief and 
patient satisfaction over replacement of epidural catheter, and thus is more prone to 
administering IV opioids in cases of inadequate pain control. Based on these finding 
however, further study should be done to determine whether the replacement of a thoracic 
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epidural is a more appropriate course of action rather than administration of IV PCA for 
presumed TEA failure.  
As detailed in Table 5, patients received a variety of postoperative analgesic 
regimens. This lack of standardization could have impacted the outcomes. However, 
Table 5 also shows that a majority of patients had the same medication mixture 
(bupivacaine 0.25% with 2mcg/ml of hydromorphone) and all patients in the TEA alone 
group received epidural opioids. The only patients receiving a plain local anesthetic also 
received systemic opioids. Additionally, all but one patient was given a combination of 
bupivacaine and hydromorphone. It is worth noting that the addition of epidural opioids 
to local anesthetic has not been shown to prolong POI.13 
 As mentioned earlier, the size and location of a patient’s hernia may necessitate a 
PCS as compared to more traditional approaches. This being said, there is a correlation 
between the extent of bowel trauma/manipulation and the occurrence of prolonged 
postoperative ileus.18 The variable nature of hernia location is an inevitable variable 
which could confound results based on the degree of bowel interaction during surgery. 
An attempt to normalize this was made be the fact all surgeries with concurrent bowel 
surgery were removed from study. 
 The indicator used for time to bowel recovery was the POD on which a patient 
was advanced to a full diet. While there have been several metrics previously used in the 
literature to define bowel recovery, such as time to first flatus and first bowel movement, 
there is currently no universally accepted point for recovery of bowel function. The 
endpoint used in this study was chosen based on the fact is was a reliably documented 
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event, which was easily obtained from the patients’ medical record. It is worth noting that 
although a patient’s diet was advanced to solid food, they might not have tolerated that 
particular diet, and this might not have been reliably apparent during chart review. 
Additionally, there are several factors that could impact when a patient is discharged 
from the hospital, which are out of the control of the care team. If the study was 
performed prospectively, narrowly defined criteria for discharge readiness would be 
drafted and utilized to provide a more accurate marker for an outcome.  
 Lastly, when comparing demographics in the secondary analysis (Table 3) there 
was a statistical significance between the TEA alone group and systemic opioid group 
when it came to the age of the patients. While this may have played a role in the 
secondary findings, increased age is actually viewed as a risk factor for the development 
and prolonging of postoperative ileus.6 If anything, this finding would have skewed 
results in the direction of the younger group (systemic opioids) and only further 
strengthens the argument for the benefit of TEA.  
 Despite these potential setbacks, the study also had several strengths. Due to its 
size, with over 100 analyzed patients, the groups of patients were demographically well 
matched in both analyses, as demonstrated by the basic data points along with the CCI. 
Additionally, all surgeries took place at the same hospital, and all attempts to minimize 
skewed results were taken by removing patients who had undergone concurrent bowel 
surgery. Although set criteria was not possible for advancement of diet or discharge from 
hospital, and there was variance in the epidural solution, this study is likely generalizable 
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to clinical practice where these variables are usually not standardized and differ based on 
the clinicians involved.  
 While a prospective study may prove beneficial to further investigate the benefits 
of TEA for patients undergoing herniorrhaphy by open PCS, the results of this study 
suggest that the optimum postoperative analgesic regimen for patients undergoing this 
surgery is TEA along with the avoidance of systemic opioids whenever possible. This 
combination allowed for faster bowel recovery and a shorter LOS in the hospital.  
  
 24 
REFERENCES 
1. Bauer, A. J., & Boeckxstaens, G. E. (2004). Mechanisms of postoperative 
ileus. Neurogastroenterology & Motility, 16, 54–60. https://doi.org/10.1111/j.1743-
3150.2004.00558.x 
2. Bauer, A. J., Sarr, M. G., & Szurszewski, J. H. (1991). Opioids inhibit neuromuscular 
transmission in circular muscle of human and baboon 
jejunum. Gastroenterology, 101(4), 970–976. 
3. Bauer, A. J., & Szurszewski, J. H. (1991). Effect of opioid peptides on circular 
muscle of canine duodenum. The Journal of Physiology, 434, 409–422. 
4. Block, B. M., Liu, S. S., Rowlingson, A. J., Cowan, A. R., Cowan, J. A., & Wu, C. L. 
(2003). Efficacy of postoperative epidural analgesia: a meta-analysis. Journal of the 
American Medical Association, 290(18), 2455–2463. 
https://doi.org/10.1001/jama.290.18.2455 
5. Blumenthal, S., Borgeat, A., Nadig, M., & Min, K. (2006). Postoperative analgesia 
after anterior correction of thoracic scoliosis: a prospective randomized study 
comparing continuous double epidural catheter technique with intravenous 
morphine. Spine, 31(15), 1646–1651. 
https://doi.org/10.1097/01.brs.0000224174.54622.1b 
6. Bragg, D., El-Sharkawy, A. M., Psaltis, E., Maxwell-Armstrong, C. A., & Lobo, D. 
N. (2015). Postoperative ileus: Recent developments in pathophysiology and 
management. Clinical Nutrition (Edinburgh, Scotland), 34(3), 367–376. 
https://doi.org/10.1016/j.clnu.2015.01.016 
7. Burger, J. W. A., Luijendijk, R. W., Hop, W. C. J., Halm, J. A., Verdaasdonk, E. G. 
G., & Jeekel, J. (2004). Long-term Follow-up of a Randomized Controlled Trial of 
Suture Versus Mesh Repair of Incisional Hernia. Annals of Surgery, 240(4), 578–585. 
https://doi.org/10.1097/01.sla.0000141193.08524.e7 
8. Collins, S. M., Hurst, S. M., Main, C., Khan, E. S. I., Blennerhassett, P., & Swain, M. 
(1992). Effect of Inflammation of Enteric Nerves Cytokine-Induced Changes in 
Neurotransmitter Content and Releasea. Annals of the New York Academy of 
Sciences, 664(1), 415–424. https://doi.org/10.1111/j.1749-6632.1992.tb39780.x 
9. Criss, C. N., Petro, C. C., Krpata, D. M., Seafler, C. M., Lai, N., Fiutem, J., … Rosen, 
M. J. (2014). Functional abdominal wall reconstruction improves core physiology and 
quality-of-life. Surgery, 156(1), 176–182. https://doi.org/10.1016/j.surg.2014.04.010 
 25 
10. de Leon-Casasola, O. A., Karabella, D., & Lema, M. J. (1996). Bowel function 
recovery after radical hysterectomies: thoracic epidural bupivacaine-morphine versus 
intravenous patient-controlled analgesia with morphine: a pilot study. Journal of 
Clinical Anesthesia, 8(2), 87–92. 
11. Freise, H., & Van Aken, H. K. (2011). Risks and benefits of thoracic epidural 
anaesthesia. British Journal of Anaesthesia, 107(6), 859–868. 
https://doi.org/10.1093/bja/aer339 
12. Gan, T. J., Robinson, S. B u., Oderda, G. M., Scranton, R., Pepin, J., & 
Ramamoorthy, S. (2015). Impact of postsurgical opioid se and ileus on economic 
outcomes in gastrointestinal surgeries. Current Medical Research and 
Opinion, 31(4), 677–686. https://doi.org/10.1185/03007995.2015.1005833 
13. Guay, J., Nishimori, M., & Kopp, S. L. (2016). Epidural Local Anesthetics Versus 
Opioid-Based Analgesic Regimens for Postoperative Gastrointestinal Paralysis, 
Vomiting, and Pain After Abdominal Surgery: A Cochrane Review. Anesthesia and 
Analgesia, 123(6), 1591–1602. https://doi.org/10.1213/ANE.0000000000001628 
14. Holte, K., & Kehlet, H. (2000). Postoperative ileus: a preventable event. The British 
Journal of Surgery, 87(11), 1480–1493. https://doi.org/10.1046/j.1365-
2168.2000.01595.x 
15. Hultman, C. S., Tong, W. M. Y., Kittinger, B. J., Cairns, B., Overby, D. W., & Rich, 
P. B. (2011). Management of recurrent hernia after components separation: 10-year 
experience with abdominal wall reconstruction at an academic medical center. Annals 
of Plastic Surgery, 66(5), 504–507. https://doi.org/10.1097/SAP.0b013e31820b3d06 
16. Jones, C. M., Winder, J. S., Potochny, J. D., & Pauli, E. M. (2016). Posterior 
Component Separation with Transversus Abdominis Release: Technique, Utility, and 
Outcomes in Complex Abdominal Wall Reconstruction. Plastic and Reconstructive 
Surgery, 137(2), 636–646. https://doi.org/10.1097/01.prs.0000475778.45783.e2 
17. Jørgensen, H., Fomsgaard, J. S., Dirks, J., Wetterslev, J., Andreasson, B., & Dahl, J. 
B. (2001). Effect of peri‐ and postoperative epidural anaesthesia on pain and 
gastrointestinal function after abdominal hysterectomy. BJA: British Journal of 
Anaesthesia, 87(4), 577–583. https://doi.org/10.1093/bja/87.4.577 
18. Kalff, J. C., Schraut, W. H., Simmons, R. L., & Bauer, A. J. (1998). Surgical 
manipulation of the gut elicits an intestinal muscularis inflammatory response 
resulting in postsurgical ileus. Annals of Surgery, 228(5), 652–663. 
 26 
19. Kehlet, H., Wilkinson, R. C., Fischer, H. B. J., Camu, F., & Prospect Working Group. 
(2007). PROSPECT: evidence-based, procedure-specific postoperative pain 
management. Best Practice & Research. Clinical Anaesthesiology, 21(1), 149–159. 
20. Krpata DM, Blatnik JA, Novitsky YW, Rosen MJ. Posterior and open anterior 
components separations: a comparative analysis. American Journal Surgery. 
2012;203:318-322. 
21. Ko, J. H., Wang, E. C., Salvay, D. M., Paul, B. C., & Dumanian, G. A. (2009). 
Abdominal wall reconstruction: lessons learned from 200 “components separation” 
procedures. Archives of Surgery (Chicago, Ill.: 1960), 144(11), 1047–1055. 
https://doi.org/10.1001/archsurg.2009.192 
22. Livingston, E. H., & Passaro, E. P. (1990). Postoperative ileus. Digestive Diseases 
and Sciences, 35(1), 121–132. 
23. Manion, S. C., & Brennan, T. J. (2011). Thoracic Epidural Analgesia and Acute Pain 
Management. The Journal of the American Society of Anesthesiologists, 115(1), 181–
188. https://doi.org/10.1097/ALN.0b013e318220847c 
24. Nishimori, M., Low, J. H. S., Zheng, H., & Ballantyne, J. C. (2012). Epidural pain 
relief versus systemic opioid-based pain relief for abdominal aortic surgery. The 
Cochrane Database of Systematic Reviews, (7), CD005059. 
https://doi.org/10.1002/14651858.CD005059.pub3 
25. Pereira Gomes Morais, E., Riera, R., Porfírio, G. J., Macedo, C. R., Sarmento 
Vasconcelos, V., de Souza Pedrosa, A., & Torloni, M. R. (2016). Chewing gum for 
enhancing early recovery of bowel function after caesarean section. In Cochrane 
Database of Systematic Reviews. John Wiley & Sons, Ltd. 
https://doi.org/10.1002/14651858.CD011562.pub2 
26. Pöpping, D. M., Elia, N., Marret, E., Remy, C., & Tramèr, M. R. (2008). Protective 
effects of epidural analgesia on pulmonary complications after abdominal and 
thoracic surgery: a meta-analysis. Archives of Surgery (Chicago, Ill.: 1960), 143(10), 
990–999; discussion 1000. https://doi.org/10.1001/archsurg.143.10.990 
27. Quan, H., Li, B., Couris, C. M., Fushimi, K., Graham, P., Hider, P., … Sundararajan, 
V. (2011). Updating and validating the Charlson comorbidity index and score for risk 
adjustment in hospital discharge abstracts using data from 6 countries. American 
Journal of Epidemiology, 173(6), 676–682. https://doi.org/10.1093/aje/kwq433 
28. Ready, L. B. (1999). Acute pain: lessons learned from 25,000 patients. Regional 
Anesthesia and Pain Medicine, 24(6), 499–505. 
 27 
29. Rodgers, A., Walker, N., Schug, S., McKee, A., Kehlet, H., van Zundert, A., … 
MacMahon, S. (2000). Reduction of postoperative mortality and morbidity with 
epidural or spinal anaesthesia: results from overview of randomised trials. British 
Medical Journal, 321(7275), 1493. 
30. Shi, W.-Z., Miao, Y.-L., Yakoob, M. Y., Cao, J.-B., Zhang, H., Jiang, Y.-G., … Mi, 
W.-D. (2014). Recovery of gastrointestinal function with thoracic epidural vs. 
systemic analgesia following gastrointestinal surgery. Acta Anaesthesiologica 
Scandinavica, 58(8), 923–932. https://doi.org/10.1111/aas.12375 
31. Tong, W. M. Y., Hope, W., Overby, D. W., & Hultman, C. S. (2011). Comparison of 
outcome after mesh-only repair, laparoscopic component separation, and open 
component separation. Annals of Plastic Surgery, 66(5), 551–556. 
https://doi.org/10.1097/SAP.0b013e31820b3c91 
32. Wu, C. L., Cohen, S. R., Richman, J. M., Rowlingson, A. J., Courpas, G. E., Cheung, 
K., … Liu, S. S. (2005). Efficacy of postoperative patient-controlled and continuous 
infusion epidural analgesia versus intravenous patient-controlled analgesia with 
opioids: a meta-analysis. Anesthesiology, 103(5), 1079-1088-1110. 
33. Shandler, L. (1965). Mechanism of Action of Local Anesthetics. Journal of the 
American Dental Society of Anesthesiology, 12(2), 62–66. 
 
   
 28 
CURRICULUM VITAE 
 
 
 
 
 
 29 
 
 
